The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: Clinical and prognostic significance

Journal of Cardiovascular Medicine

Volumn 11, Issue 9, 2010, Pages 669-677

  Pinamonti, Bruno ^a   Merlo, Marco ^a   Nangah, René ^a   Korcova, Renata ^a   Di Lenarda, Andrea ^b   Barbati, Giulia ^a   Sinagra, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Cardiovascular Center   (Italy)

Author keywords

hypertrophic cardiomyopathy; prognosis; restrictive filling pattern; systolic dysfunction

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VERAPAMIL;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART SIZE; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROGNOSIS; SURVIVAL RATE; SYSTOLIC DYSFUNCTION;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; DIASTOLE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART TRANSPLANTATION; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 77955229464     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283383355     Document Type: Article

References (47)

1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al., Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/ European Society of Cardiology clinical export consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003; 42:1687-1713.
2. Louie EK, Edwards LC III. Hypertrophic cardiomyopathy. Progr Cardiovasc Dis 2004; 36:275-308.
3. Maron BJ, Spirito P, Green KJ, Wesley YE, Bonow RO, Arce J. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987; 10:733-742.
4. Byrg RJ, Pearson AC, Williams GA, Labowitz AJ. Left ventricular systolic and diastolic abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy.AmJ Cardiol 1987; 59:925-931.
5. Rakowski H, Sasson Z, Wigle ED. Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. J Am Soc Echo 1988; 1:31-47.
6. Takenaka K, Dabestani A, Gardin JM, Russell D, Clark S, Allfie A, et al. Left ventricular filling in hypertrophic cardiomyopathy: a pulsed Doppler echocardiographic study. J Am Coll Cardiol 1986; 27:1263-1271. (Pubitemid 16100348)
7. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988; 12:426-440.
8. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. J Am Coll Cardiol 1997; 30:8-18.
9. Pinamonti B, Di Lenarda A, Nucifora G, Gregori D, Perkan A, Sinagra G. Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study. Eur J Echocardiogr 2008; 9:466-471.
10. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng CP. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995; 92:1933-1939.
11. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations. J Am Coll Cardiol 1993; 22:808-815.
12. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, et al. Prevalence, clinical profile, and significance of left ventricular remodelling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006; 114:216-225.
13. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60:123-129.
14. Maron BJ, Spirito P. Implications of left ventricular remodelling in hypertrophic cardiomyopathy. Am J Cardiol 1998; 81:1339-1344.
15. Hina K, Kusachi S, Iwasaki K, Nogami K, Moritani H, Kita T, et al. Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value. Clin Cardiol 1993; 16:403-407.
16. Biagini E, Coccolo F, Ferlito M, Perugini E, Rocchi G, Bacchi-Reggiani L, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy. Prevalence, incidence, risk factors and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 2005; 46:1543-1550.
17. Sahn DJ, De Maria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American society of echocardiography: recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1988; 58:1072-1083.
18. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography. J Am Soc Echo 1989; 2:358-367.
19. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, et al. 24th Bethesda conference: cardiac transplantation. Task force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 1993; 22:21-31.
20. Grambsh P, Therneau T. Proportional hazard tests and diagnostics based on weighted residuals. Biometrika 1994; 81:515-526.
21. Hanley JA, McNeil BJ. The meaning and the use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
22. Efron B, Tibshirani RJ. An introduction to the bootstrap. London: Chapman & Hall; 1993.
23. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 2001; 33:655-670.
24. Watkins H. Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies. Circulation 2003; 107:1344-1346.
25. Roberts R, Sigwart U. New concepts in hypertrophic cardiomyopathies, part I. Circulation 2001; 104:2113-2116. (Pubitemid 33027055)
26. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995; 26:1699-1708.
27. Hecht GM, Klues HG, Roberts WC, Maron BJ. Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22:489-497.
28. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K. Familial hypertrophic cardiomyopathy: from mutation to functional defects. Circ Res 1998; 83:580-593. (Pubitemid 28427741)
29. Shah PM. Hypertrophic cardiomyopathy and diastolic dysfunction. J Am Coll Cardiol 2003; 42:286-287.
30. Factor SM, Butany J, Sole MJ, Wigle ED, Williams WC, Rojkind M. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1991; 17:1343-1351.
31. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15:808-813. (Pubitemid 20101571)
32. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH III, Zoghbi WA, Quinones MA. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999; 99:254-261.
33. Matsumura Y, Elliott PM, Videe MS, Sorajja P, Doi Y, McKenna WJ. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart 2002; 87:247-251.
34. Nishimura RA, Appleton CP, Redfiel MM, Ilstrup DM, Holmes DR, Tajik AJ. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996; 28:1226-1233.
35. Shirani J, Maron BJ, Cannon RO III, Shahin S, Roberts WC. Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. Am J Cardiol 1993; 72:434-440.
36. Geske JB, Sorajja P, Nishimura RA, Ommen SR. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy. Correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 2007; 116:2702-2708.
37. Pozzoli M, Capomolla S, Pinna G, Cobelli F, Tavazzi L. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol 1996; 27:883-893. (Pubitemid 26104870)
38. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995; 26:1529-1536.
39. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large nonreferral-base patient population. Circulation 2000; 102:858-864.
40. McKenna WJ, Mogensen J, Elliott PM. Role of genotyping in risk factor assessment for sudden death in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39:2049-2051.
41. Kofflard MJM, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003; 41:987-993.
42. Fay WP, Taliercio CP, Ilstrup DM, Tajik AJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol 1990; 16:821-826.
43. Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol 1997; 29:604-612.
44. Traversi E, Pozzoli M, Cioffi G, Capomolla S, Forni G, Sanarico M, et al. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J 1996; 132:809-819.
45. Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 2006; 98:960-965.
46. Spirito P, Bellone P, Harris KM, BernabòP, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342:1778-1785.
47. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cadiomyopathy. N Engl J Med 2003; 348:295-303. (Pubitemid 36119984)